Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Mar;33(3):342–345. doi: 10.1111/j.1365-2125.1992.tb04049.x

Dose-response study with high-dose inhaled salmeterol in healthy subjects.

J G Maconochie 1, J K Forster 1
PMCID: PMC1381289  PMID: 1349491

Abstract

A double-blind, placebo-controlled, cross-over study in 10 healthy male subjects has been carried out to investigate the non-pulmonary effects of single inhaled doses of salmeterol 100 micrograms, 200 micrograms and 400 micrograms and salbutamol 400 micrograms from a metered-dose inhaler. At all doses tested, salmeterol produced statistically significant changes in pulse rate, tremor, blood glucose and plasma potassium concentrations, compared with placebo. All changes were dosed related. A number of dose-related adverse events including tremor, awareness of heart beat and headache were reported after salmeterol administration.

Full text

PDF
342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crane J., Burgess C., Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax. 1989 Feb;44(2):136–140. doi: 10.1136/thx.44.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hall J. A., Petch M. C., Brown M. J. Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res. 1989 Sep;65(3):546–553. doi: 10.1161/01.res.65.3.546. [DOI] [PubMed] [Google Scholar]
  3. Lipworth B. J., Clark R. A., Dhillon D. P., Brown R. A., McDevitt D. G. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol. 1988 Nov;26(5):527–533. doi: 10.1111/j.1365-2125.1988.tb05292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lipworth B. J., Clark R. A., Dhillon D. P., McDevitt D. G. Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol. Eur J Clin Pharmacol. 1990;38(2):203–205. doi: 10.1007/BF00265986. [DOI] [PubMed] [Google Scholar]
  5. Scheinin M., Koulu M., Laurikainen E., Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol. 1987 Nov;24(5):645–653. doi: 10.1111/j.1365-2125.1987.tb03224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Struthers A. D., Reid J. L., Whitesmith R., Rodger J. C. Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J. 1983 Jan;49(1):90–93. doi: 10.1136/hrt.49.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Vick R. L., Todd E. P., Luedke D. W. Epinephrine-induced hypokalemia: relation to liver and skeletal muscle. J Pharmacol Exp Ther. 1972 Apr;181(1):139–146. [PubMed] [Google Scholar]
  8. Whitsett T. L., Manion C. V., Wilson M. F. Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo. Br J Clin Pharmacol. 1981 Aug;12(2):195–200. doi: 10.1111/j.1365-2125.1981.tb01200.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wong C. S., Pavord I. D., Williams J., Britton J. R., Tattersfield A. E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 1990 Dec 8;336(8728):1396–1399. doi: 10.1016/0140-6736(90)93099-b. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES